IOP Measurements Using ORA After ACXL in Keratoconus

IOP Readings Before and After Accelerated Corneal Collagen Crosslinking (CXL) Clinical Trial

Official title:

Intraocular Pressure Measurements Using Ocular Response Analyzer After Accelerated Corneal Collagen Crosslinking With Riboflavin and Ultraviolet A in Keratoconus

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04464083
• Other study ID #: R110
• Status: Completed
• Start date: April 12, 2020
• Est. completion date: October 15, 2020

Study information

• Verified date: February 2021
• Source: Fayoum University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators measured IOP by Goldmann applanation tonometry(GAT) before and 6 months after accelerated 8 minutes CXL in using Avedro Kxl ,and correlated with corneal resistance factor(CRF)using ORA, AC angle and CCT using Scheimpflug imaging.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: October 15, 2020
• Est. primary completion date: October 15, 2020
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• KC patient indicated for CXL

Exclusion Criteria:

• Advanced KC Glaucoma patients

Related Conditions & MeSH terms

• IOP Readings Before and After Accelerated Corneal Collagen Crosslinking (CXL)
• Keratoconus

Intervention

Diagnostic Test:
• IOP Measurment
To determine IOP readings before and after accelerated corneal collagen crosslinking (CXL)

Locations

Country	Name	City	State
Egypt	Fayoum University	Fayoum

Sponsors (1)

Lead Sponsor	Collaborator
Fayoum University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To determine IOP readings before and after accelerated corneal collagen crosslinking		April-October 2020